Tmates

About Tmates

Tmates has been operating since 2022 and offers one of the broadest medication menus we have encountered, including both brand-name options like Wegovy and Zepbound as well as compounded semaglutide, tirzepatide, and phentermine. What immediately stands out is the pricing: at $99 to $167 per month, Tmates is among the most affordable providers in the GLP-1 telehealth space, particularly impressive given its inclusion of brand-name medications. The platform also accepts insurance, which could significantly reduce costs for eligible patients.

From a support perspective, Tmates distinguishes itself with high ongoing support — a rating we do not assign lightly in our reviews. This means patients can expect consistent check-ins, accessible customer service, and a more hands-on experience than the typical “prescribe and forget” telehealth model. The platform also holds a B+ rating with the Better Business Bureau, indicating a generally positive track record with consumer complaints and business practices. This level of accreditation adds a layer of accountability that many competitors lack.

The inclusion of phentermine alongside GLP-1 medications is an unusual offering that broadens Tmates’ appeal. Phentermine is an older, well-established weight loss medication that works through a different mechanism than GLP-1 receptor agonists, and some patients may benefit from this alternative or even a combination approach under medical supervision. Having multiple medication pathways available through a single provider simplifies the treatment journey for patients who may need to adjust their protocol.

The main weakness in Tmates’ profile is its extremely limited review history. The platform’s Trustpilot page shows a 3.2 rating based on just 1 review, which provides essentially no useful data about the broader patient experience. While the BBB rating partially compensates for this gap, prospective patients should be aware that independent patient feedback is virtually nonexistent. The platform also does not offer lab testing or dietitian access, which keeps it from reaching the top tier of clinical comprehensiveness.

Despite the thin review history, Tmates presents a compelling package on paper: affordable pricing, insurance acceptance, a wide medication selection including brand-name options, strong ongoing support, and BBB accreditation. If the platform can build a more substantial body of patient reviews over time, it has the potential to move up in our rankings. For now, it earns a solid mid-range score that reflects genuine promise tempered by the need for more external validation.

Tmates GLP-1 Medications

At a Glance